Analysis of tandospirone (SM-3997) interactions with neurotransmitter receptor binding sites

@article{Hamik1990AnalysisOT,
  title={Analysis of tandospirone (SM-3997) interactions with neurotransmitter receptor binding sites},
  author={Anne Hamik and Donna Oksenberg and Christine T. Fischette and Stephen J. Peroutka},
  journal={Biological Psychiatry},
  year={1990},
  volume={28},
  pages={99-109}
}
View on Elsevier
doi.org
95 Citations
Highly Influential Citations
5
Background Citations
29
Methods Citations
3

95 Citations

Tandospirone and its metabolite, 1-(2-pyrimidinyl)-piperazine—II. Effects of acute administration of 1-PP and long-term adminstration of tandospirone on noradrenergic neurotransmission

Effect of tandospirone, a serotonin-1A receptor partial agonist, on information processing and locomotion in dizocilpine-treated rats

Findings suggest that behavioural changes induced by tandospirone are not fully blocked by 5-HT1A antagonists and that tandosphereirone (5 mg/kg) potentiates the effect of MK-801, and point to an interaction between NMDA and 5- HT1A receptors.

Tandospirone potentiates the fluoxetine-induced increases in extracellular dopamine via 5-HT1A receptors in the rat medial frontal cortex

Tandospirone and its metabolite, 1-(2-pyrimidinyl)-piperazine—I. Effects of acute and long-term administration of tandospirone on serotonin neurotransmission

Characterization of 5-hydroxytryptamine1A properties of flesinoxan: In Vivo electrophysiology and hypothermia study

In vivo drug action of tandospirone at 5-HT1A receptor examined using positron emission tomography and neuroendocrine response

Despite the significant effect on growth hormone and body temperature, a clinical dose of tandospirone had a negligible effect on [11C]WAY 100635 binding, which indicates that the agonist produces a pharmacological effect without measurable occupancy, and a new index other than occupancy will be required for the in vivo evaluation of agonists.

Tandospirone suppresses impulsive action by possible blockade of the 5-HT1A receptor.

Tandospirone could be a therapeutic candidate for impulsivity-related disorders and may be due to the antagonistic action of the 5-HT1A receptor.

Trazodone and its active metabolite m-chlorophenylpiperazine as partial agonists at 5-HT1A receptors assessed by [35S]GTPγS binding

The agonist properties of trazodone and its active metabolite, m-chlorophenylpiperazine (m-CPP), at 5-HT1A receptors are elucidated by means of the guanosine-5′-O-(3-[ 35S]thio)-triphosphate ([35S]GTPγS) binding assay.

The activity of the serotonergic 5-HT1A receptor is modulated by voltage and sodium levels

The effects of azapirones on serotonin1A neurons of the dorsal raphe.

...

References

SHOWING 1-10 OF 37 REFERENCES

Selective interaction of novel anxiolytics with 5-hydroxytryptamine1A receptors

Interaction of SM-3997 with serotonin receptors in rat brain.

Results suggest that the action of SM-3997 may be mediated via central 5-HT1A receptors but not the BZ-GABA receptor complex.

Characterization of the putative anxiolytic SM-3997 recognition sites in rat brain.

Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT

3H-PAT seems to be a useful ligand for studying the biochemical and pharmacological characteristics of presynaptic autoreceptors in selected regions of rat brain.

Characterization of the 5-hydroxytryptamine1a receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes.

  • M. De VivoS. Maayani
  • Biology, Chemistry
    The Journal of pharmacology and experimental therapeutics
  • 1986
The concentration-response data show that the inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes is mediated by a receptor with the characteristics of the 5-HT1A binding site, and it is proposed that this response is suitable for measuring activities and affinities of drugs acting at 5- HT1A receptors.

Pharmacological properties of SM-3997: a new anxioselective anxiolytic candidate.

The results show that SM-3997 is a new anxioselective anxiolytic agent which is weaker than buspirone in the dopaminergic neuron system.

Effects of the putative anxiolytic SM-3997 on central monoaminergic systems

Selective antagonists of benzodiazepines

The main properties of a representative of this novel class of specific benzodiazepine antagonists are described, whose unique pharmacological activity is to prevent or abolish in a highly selective manner at the receptor level all the characteristic centrally mediated effects of active Benzodiazepines.

Buspirone analogues. 2. Structure-activity relationships of aromatic imide derivatives.

Several analogues of the novel anxiolytic buspirone were synthesized and evaluated in vivo for tranquilizing activity and their ability to reverse neuroleptic-induced catalepsy and general structure-activity relationships highlight compounds 17, 21, and 32 as having anticonflict activity.

Benzodiazepines and barbiturates: turnover changes in central 5-hydroxytryptamine pathways.